| dc.contributor.author | Ayuda Durán, María Begoña | |
| dc.contributor.author | Garzón García, Lidia | |
| dc.contributor.author | González Manzano, Susana | |
| dc.contributor.author | Santos Buelga, Celestino | |
| dc.contributor.author | González Paramás, Ana M. | |
| dc.date.accessioned | 2025-01-23T08:37:54Z | |
| dc.date.available | 2025-01-23T08:37:54Z | |
| dc.date.issued | 2024 | |
| dc.identifier.citation | Ayuda-Durán, B., Garzón-García, L., González-Manzano, S., Santos-Buelga, C., & González-Paramás, A. M. (2024). Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans. Antioxidants, 13(1), 79. https://doi.org/10.3390/antiox13010079 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/10366/162324 | |
| dc.description | This research was financed by Grant PID2019-106167RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, Consejería de Educación (Project SA093P20), and Strategic Research Programs for Units of Excellence from Junta de Castilla y León (ref. CLU-2018-04). Lidia Garzón-García was financed by Grant PRE2020-095876 associated to the project MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. Financiadores National Institutes of Health United States P40 OD010440 European Social Fund Plus European Union Consejería de Educación, Junta de Castilla y León Spain SA093P20 | es_ES |
| dc.description.abstract | Medical therapies to avoid the progression of Alzheimer’s disease (AD) are limited to date. Certain diets have been associated with a lower incidence of neurodegenerative diseases. In particular, the regular intake of foods rich in polyphenols, such as epicatechin (EC), could help prevent or mitigate AD progression. This work aims to explore the neuroprotective effects of EC using different transgenic strains of Caenorhabditis elegans, which express human Aβ1-42 peptides and contribute to elucidating the mechanisms involved in the effects of EC in AD. The performed assays indicate that this flavan-3-ol was able to reduce the signs of β-amyloid accumulation in C. elegans, improving motility and chemotaxis and increasing survival in transgenic strain peptide producers compared to nematodes not treated with EC. The neuroprotective effects exhibited by EC in C. elegans could be explained by the modulation of inflammation and stress-associated genes, as well as autophagy, microgliosis, and heat shock signaling pathways, involving the regulation of cpr-5, epg-8, ced-7, ZC239.12, and hsp-16 genes. Overall, the results obtained in this study support the protective effects of epicatechin against Aβ-induced toxicity. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | https://www.mdpi.com/2076-3921/13/1/79 | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | neuroprotection | es_ES |
| dc.subject | flavonoids | es_ES |
| dc.subject | chemotaxis | es_ES |
| dc.subject | gene expression | es_ES |
| dc.subject | paralysis | es_ES |
| dc.subject.mesh | Chemotaxis | * |
| dc.subject.mesh | Flavonoids | * |
| dc.subject.mesh | Gene Expression | * |
| dc.subject.mesh | Paralysis | * |
| dc.title | Insights into the neuroprotective potential of epicatechin: effects against Aβ-Induced toxicity in caenorhabditis elegans | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.3390/antiox13010079 | es_ES |
| dc.identifier.doi | 10.3390/ANTIOX13010079 | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | es_ES |
| dc.identifier.essn | 2076-3921 | |
| dc.journal.title | Antioxidants | es_ES |
| dc.volume.number | 13 | es_ES |
| dc.issue.number | 1 | es_ES |
| dc.page.initial | 79 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | flavonoides | * |
| dc.subject.decs | quimiotaxis | * |
| dc.subject.decs | expresión génica | * |
| dc.subject.decs | parálisis | * |
| dc.description.project | This research was financed by Grant PID2019-106167RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, Consejería de Educación (Project SA093P20), and Strategic Research Programs for Units of Excellence from Junta de Castilla y León (ref. CLU-2018-04). Lidia Garzón-García was financed by Grant PRE2020-095876 associated to the project MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. Financiadores National Institutes of Health United States P40 OD010440 European Social Fund Plus European Union Consejería de Educación, Junta de Castilla y León Spain SA093P20 | es_ES |
Parcourir
Tout GredosCommunautés & CollectionsPar date de publicationAuteursSujetsTitresCette collectionPar date de publicationAuteursSujetsTitres
Mon compte
Statistiques
ENLACES Y ACCESOS
Derechos de autorPolíticasGuías de autoarchivoFAQAdhesión USAL a la Declaración de BerlínProtocolo de depósito, modificación y retirada de documentos y datosSolicitud de depósito, modificación y retirada de documentos y datos








